Cargando…
Pharmacokinetic modeling optimizes inhibition of the ‘undruggable’ EWS-FLI1 transcription factor in Ewing Sarcoma
Transcription factors have long been deemed ‘undruggable’ targets for therapeutics. Enhanced recognition of protein biochemistry as well as the need to have more targeted approaches to treat cancer has rendered transcription factors approachable for therapeutic development. Since transcription facto...
Autores principales: | Hong, Sung-Hyeok, Youbi, Sarah. E., Hong, S. Peter, Kallakury, Bhaskar, Monroe, Phillip, Erkizan, Hayriye V, Barber-Rotenberg, Julie S., Houghton, Peter, Üren, Aykut, Toretsky, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964211/ https://www.ncbi.nlm.nih.gov/pubmed/24481407 |
Ejemplares similares
-
Small molecule selected to disrupt oncogenic protein EWS-FLI1 interaction with RNA Helicase A inhibits Ewing's Sarcoma
por: Erkizan, Hayriye V., et al.
Publicado: (2009) -
Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity
por: Schlottmann, Silke, et al.
Publicado: (2012) -
RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1
por: Erkizan, Hayriye Verda, et al.
Publicado: (2015) -
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
por: Barber-Rotenberg, Julie S., et al.
Publicado: (2012) -
Synthesis and Structure–Activity
Relationship
Studies of Small Molecule Disruptors of EWS-FLI1 Interactions in Ewing’s
Sarcoma
por: Tosso, Perrer N., et al.
Publicado: (2014)